e-Therapeutics plc Notification by Director (2414G)
May 25 2017 - 5:20AM
UK Regulatory
TIDMETX
RNS Number : 2414G
e-Therapeutics plc
25 May 2017
E-THERAPEUTICS PLC
("e-Therapeutics" or the "Company")
NOTIFICATION BY DIRECTOR
Oxford, UK, 25 May 2017 - e-Therapeutics plc (AIM: ETX), the
drug discovery company, announces that it was informed on 25 May
2017 by the Company's Chairman, Mr Iain Ross, that on the afternoon
of 24 May 2017, Redx Pharma plc ("Redx"), the drug discovery and
development company, announced that it had gone into
administration.
Redx's shares were suspended from trading on AIM as at 4.35pm
yesterday afternoon. Mr Ross was appointed Chairman of Redx on 1
May 2017.
This announcement is being made pursuant to the requirements of
AIM Rule 17 and Schedule 2(g)(v) to the AIM Rules for
Companies.
For further information, please contact:
Contacts:
e-Therapeutics plc Tel: +44 (0) 1993
Ray Barlow, CEO 883 125
Steve Medlicott, Finance www.etherapeutics.co.uk
Director
Numis Securities Limited Tel: +44 (0) 207
Michael Meade / Freddie 260 1000
Barnfield www.numis.com
(Corporate Finance)
James Black (Corporate
Broking)
Instinctif Partners Tel: +44 (0) 207
Melanie Toyne-Sewell / 457 2020
Alex Shaw Email: e-therapeutics@instinctif.com
About e-Therapeutics plc
e-Therapeutics is a drug discovery company with a unique and
proprietary in silico discovery platform. The Company is applying
its computational platform to the discovery of new drug candidates
for which it can secure robust intellectual property rights.
The therapeutic focus of the Company's discovery activity is in
areas of complex disease with unmet medical need, including
immuno-oncology. The business model is to partner these preclinical
drug candidates.
e-Therapeutics is headquartered in Oxford. For more information
about the Company please visit www.etherapeutics.co.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAOKPDDKBKDAPB
(END) Dow Jones Newswires
May 25, 2017 06:20 ET (10:20 GMT)
E-therapeutics (LSE:ETX)
Historical Stock Chart
From Apr 2024 to May 2024
E-therapeutics (LSE:ETX)
Historical Stock Chart
From May 2023 to May 2024